Cell surface antigens of human astrocytoma defined by mouse monoclonal antibodies: identification of astrocytoma subsets - PubMed (original) (raw)

Cell surface antigens of human astrocytoma defined by mouse monoclonal antibodies: identification of astrocytoma subsets

J G Cairncross et al. Proc Natl Acad Sci U S A. 1982 Sep.

Abstract

The surface antigens of cultured human malignant astrocytomas were analyzed by using mouse monoclonal antibodies. BALB/c mice were immunized repeatedly with either SK-MG-1 [a glial fibrillary acidic protein (GFA)-negative astrocytoma line] or SK-AO2 (a GFA-positive astrocytoma line). After fusion with NS/1 mouse myeloma cells, 12 antibody-producing clones were selected for detailed study. Serological analysis permitted the identification of nine distinct antigenic systems. Four monoclonal antibodies (Ab AJ225, Ab AO10, Ab AJ8, and Ab AO122) identified cell surface antigens preferentially expressed on tumors of neuroectodermal origin, and these antibodies subdivided the astrocytoma panel into distinguishable subsets. The determinant detected by Ab AO10 and Ab AJ8 showed mutually exclusive expression on the astrocytoma lines. The AO10 and AJ8 phenotypes appeared to reflect the differentiation state of the cultured cells; 4/7 AO10-positive astrocytomas expressed GFA, an intracellular astrocyte differentiation antigen, whereas all AJ8-positive astrocytoma (9/9) were GFA-negative. Five antibodies (Ab AJ10, Ab AJ9, Ab AJ17, Ab AJ425, and Ab AJ2) recognized determinants widely distributed on normal and malignant cells. Four antibodies defined in this study precipitated proteins from reduced preparations of radioisotope-labeled SK-MG-1 and SK-AO2 cells: Ab AJ225 (Mr 145,000); Ab AO122 (Mr265,000); Ab AJ10 (Mrs 195,000 and 165,000); and Ab AJ2 (Mrs 170,000, 140,000, 140,000, and 28,000).

PubMed Disclaimer

Cited by

Immunobiology of brain tumors.
Frank E, de Tribolet N. Frank E, et al. Neurosurg Rev. 1986;9(1-2):31-7. doi: 10.1007/BF01743051. Neurosurg Rev. 1986. PMID: 3090477
Identification of glioblastoma-specific antigens expressed in patient-derived tumor cells as candidate targets for chimeric antigen receptor T cell therapy.
Nakagawa T, Kijima N, Hasegawa K, Ikeda S, Yaga M, Wibowo T, Tachi T, Kuroda H, Hirayama R, Okita Y, Kinoshita M, Kagawa N, Kanemura Y, Hosen N, Kishima H. Nakagawa T, et al. Neurooncol Adv. 2022 Nov 15;5(1):vdac177. doi: 10.1093/noajnl/vdac177. eCollection 2023 Jan-Dec. Neurooncol Adv. 2022. PMID: 36601313 Free PMC article.
Cell surface molecules of human melanoma. Immunohistochemical analysis of the gp57, GD3, and mel-CSPG antigenic systems.
Garin-Chesa P, Beresford HR, Carrato-Mena A, Oettgen HF, Old LJ, Melamed MR, Rettig WJ. Garin-Chesa P, et al. Am J Pathol. 1989 Feb;134(2):295-303. Am J Pathol. 1989. PMID: 2916650 Free PMC article.
Cell surface antigens of human ovarian and endometrial carcinoma defined by mouse monoclonal antibodies.
Mattes MJ, Cordon-Cardo C, Lewis JL Jr, Old LJ, Lloyd KO. Mattes MJ, et al. Proc Natl Acad Sci U S A. 1984 Jan;81(2):568-72. doi: 10.1073/pnas.81.2.568. Proc Natl Acad Sci U S A. 1984. PMID: 6582512 Free PMC article.
Immunohistochemical analysis of the A4 and AO10 (gp110) cell-surface antigens of human astrocytoma.
Garin-Chesa P, Beresford HR, Walker S, Rettig WJ. Garin-Chesa P, et al. Am J Pathol. 1990 Apr;136(4):797-807. Am J Pathol. 1990. PMID: 2183624 Free PMC article.

References

1. J Biol Chem. 1975 May 25;250(10):4007-21 - PubMed
1. Proc Natl Acad Sci U S A. 1976 Sep;73(9):3278-82 - PubMed
1. Nature. 1976 Oct 14;263(5578):563-7 - PubMed
1. Cancer Res. 1977 Sep;37(9):3406-13 - PubMed
1. Proc Natl Acad Sci U S A. 1978 Oct;75(10):5122-6 - PubMed

Cell surface antigens of human astrocytoma defined by mouse monoclonal antibodies: identification of astrocytoma subsets - PubMed (original) (raw)